Meritage Portfolio Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-76,714
Closed -$5.21M 176
2015
Q4
$5.21M Sell
76,714
-5,390
-7% -$353K 0.59% 72
2015
Q3
$5.23M Sell
82,104
-7,442
-8% -$490K 0.61% 62
2015
Q2
$5.71M Sell
89,546
-745
-0.8% -$51K 0.6% 60
2015
Q1
$6.18M Buy
90,291
+5,255
+6% +$365K 0.62% 49
2014
Q4
$5.99M Buy
85,036
+2,955
+4% +$212K 0.64% 48
2014
Q3
$5.86M Buy
82,081
+1,325
+2% +$97K 0.67% 45
2014
Q2
$6M Buy
80,756
+4,565
+6% +$330K 0.65% 44
2014
Q1
$4.94M Buy
76,191
+1,855
+2% +$120K 0.59% 70
2013
Q4
$4.41M Buy
74,336
+265
+0.4% +$14.4K 0.55% 82
2013
Q3
$3.85M Buy
74,071
+1,570
+2% +$78.9K 0.5% 102
2013
Q2
$3.43M Buy
+72,501
New +$3.69M 0.49% 105

Other funds holding AZN